Glooko Highlights Regulatory-Driven Demand for Inpatient Glycemic Management Solutions

According to a recent LinkedIn post from Glooko, the U.S. Centers for Medicare & Medicaid Services has made electronic clinical quality measure reporting for severe hypoglycemia and hyperglycemia mandatory under the Inpatient Quality Reporting program. The post highlights a Becker’s Healthcare webinar featuring Glooko’s clinical leadership alongside physicians from several major health systems.

The LinkedIn post suggests growing regulatory pressure on hospitals to standardize inpatient glycemic management and reduce variability in insulin workflows. For investors, this focus may indicate expanding demand for data-driven diabetes management tools that help providers document and meet evolving CMS quality requirements.

By positioning its experts alongside large health systems, Glooko appears to be emphasizing its role in clinical workflow standardization and compliance support rather than only outpatient diabetes management. This could support deeper enterprise relationships with health systems, potentially increasing recurring software revenue and strengthening competitive positioning in the hospital diabetes care segment.

The emphasis on eCQM reporting and guideline alignment may also point to opportunities for Glooko to integrate more closely with hospital EHR systems and quality reporting infrastructures. If such integrations scale, they could increase switching costs for customers and reinforce Glooko’s value proposition in an increasingly regulated inpatient care environment.